Компьютерное конструирование ферментативных систем, обеспечивающих синтез макролидов с заданными свойствами
Диссертация
В диссертационной работе предложен метод конструирования in silico доменных последовательностей ферментативных систем, обеспечивающих синтез макролидов с заданным профилем биологической активности. Разработана компьютерная программа Biogenerator, которая позволяет генерировать виртуальные комбинаторные библиотеки структур макролидов и последовательности доменов PKS, необходимые для их биосинтеза… Читать ещё >
Список литературы
- Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the Last 25 Years // J. Nat. Prod. 2007. — V. 70. — P. 461−477.
- Macrolide antibiotics: chemistry, biology, and practice / ed. Omura S. — 2nd ed. Academic Press, 2002. — 635 p.
- Khosla C., Zawada R.J. Generation of polyketide libraries via combinatorial biosynthesis. // Trends Biotechnol. — 1996. — V. 14. — P. 335−341.
- Hopwood D.A., Sherman D.H. Molecular genetics of polyketides and its comparison to fatty acid biosynthesis // Annu. Rev. Genet. 1990. — V. 24. -P. 37−66.
- Donadio S., Staver M.J., McAlpine J.B., Swanson S.J., Katz L. Modular organization of genes required for complex polyketide biosynthesis // Science. 1991. — V. 252. № 5006. — P. 675−679.
- Aparicio J.F., Caffrey P., Gil J.A., Zotchev S.B. Polyene antibiotic biosynthesis gene clusters // Appl Microbiol Biotechnol. 2003. — V. 61. — P. 179−188.
- Ikeda H., Nonomiya Т., Usami M., Ohta Т., Omura S. Organization of the biosynthetic gene cluster for the polyketide anthelmintic macrolide avermectin in Streptomyces avermitilis // Proc. Natl. Acad. Sci. USA — 1999.-V. 96. № 17.-P. 9509−9514.
- Anzai Y., Saito N., Tanalca M., Kinoshita K., Koyama Y., Kato F. Organization of the biosynthetic gene cluster for the polylcetide macrolide mycinamicin in Micromonospora griseorubida // FEMS Microbiol Lett. — 2003.-V. 218. № l.-P. 135−41.
- Gonzalez-Lergier J., Broadbelt L.J., Hatzimanikatis V. Theoretical Considerations and Computational Analysis of the Complexity in Polylcetide Synthesis Pathways // J. Am. Chem. Soc. 2005. — V. 127. — P. 9930−9938.
- Siani M.A., Slcillman A.G., Carreras C.W., Ashley G., Kuntz I.D., Santi D.Y. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore // J. Mol. Graph. Model. 2000. -V. 18.-P. 497−511.
- Woodward R.B. Structur und Biogenese der Malcrolide. Eine neuen Klasse von Naturstoffen // Angew. Chem. 1957. — V. 69. — P. 50−58.
- Masamune S., Bates G.S., Corcoran J.W. Macrolides. Recent progress in chemistry and biochemistry // Angew. Chem. Int. Edit. Engl. 1977. — V. 16.-P. 585−607.
- US 2 653 899. Erythromycin, its salts, and method of preparation / Inventor: Bunch R. L- McGuire J.M. Applicant: LILLY CO ELI. Publication date: 1953−09−29.
- Регистр лекарственных средств России PJIC Энциклопедия лекарств. — 15-й вып. / Гл.ред. Г. JI. Вышковский. М.: «РЛС-2007″, 2006. — с. 1488.
- Mazzei Т., Mini Е., Novelli A., Periti P. Chemistry and mode of action of Macrolides // J. Antimicrob. Chemother. 1993. Mar-31 Suppl C: l-9.
- Vannuffel P., Cocito C. Mechanism of action of streptogramins and Macrolides//Drugs 1996.-V. 51. Suppl l.-P. 20−30.
- Meyler’s side effects of drugs 15-th ed. / Ed. Aronson J.K. — Elsevier, 2006.-3994 p.
- Kostrubsky V.E., Strom S.C., Hanson J., Urda E., Rose K., Burliegh J., Zocharski P., Cai H., Sinclair J.F., Sahi J. Evaluation of Hepatotoxic Potential of Drugs by Inhibition of Bile-Acid Transport in Cultured Primary
- Human Hepatocytes and Intact Rats // Toxicological Sciences 2003. — V. 76.-P. 220−228.
- Zotchev S.B. Polyene macrolide antibiotics and their applications in human therapy // Curr. Med. Chem. 2003. — V. 10. № 3. — P. 211−223.
- Hammond S.M. Biological activity of polyene antibiotics // Prog Med Chem. 1977.- V. 14.-P. 105−179.
- Teerlink Т., de Kruijff В., Demel R.A. The action of pimaricin, etruscomycin and amphotericin В on liposomes with varying sterol content // Biochim. Biophys. Acta. 1980. -V. 599. — P. 484−492.
- Milhaud J. Permeabilizing action of filipin III on model membranes through a filipin-phospholipid binding // Biochim. Biophys. Acta. 1992. — V. 1105. № 2.-P. 307−318.
- Kobayashi J. Pharmacologically active metabolites from symbiotic microalgae in okinawan marine invertebrates // Journal of Natural Products 1989. — V. 52. № 2. — P. 225−238.
- Omura S. Splendid Gifts from Microorganisms // The achievements of S. Omura and collaboratots. 3d ed., Kitasato University, 2003.
- Negwer M., Organic-Chemical Drugs and their synonyms / 8 ed. -Weinheim: Wiley-vch Verlag GmbH, 2001.
- Oliynyk M., Brown M.J.B., Cortes J., Staunton J., Leadlay P.F. A hybrid modular polyketide synthase obtained by domain swapping // Chem. Biol. — 1996. — V. 3. -P. 833−839.
- Schwarzer D., Marahiel M.A. Multimodular biocatalysts for natural product assembly //Naturwissenschaften-2001. V. 88. -P. 93−101.
- Katz L., McDaniel R. Novel macrolides through genetic engineering // Med. Res. Rev. 1999. — V. 19. № 6. — P. 543−558.
- Cortes J., Haydock S.F., Roberts G.A., Bevitt D.J., Leadlay P.F. An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea // Nature. — 1990. — V. 348.-P. 176−178.
- Caffrey P., Lynch S., Flood E., Finnan S., Oliynyk M. Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes // Chem Biol. 2001. — V. 8. № 7. — P. 713−723.
- Campelo A.B., Gil J.A. The candicidin gene cluster from Streptomyces griseus IMRU 3570 //Microbiology.- 2002. -V. 148.-P. 51−59.
- Rawlings B.J. Type I polyketide biosynthesis in bacteria (Part A — erythromycin biosynthesis) // Nat. Prod. Rep.» 2001. — V. 18. — P. 190 227.
- Donadio S., McAlpine J.B., Sheldon P.J., Jackson M., Katz L. An erythromycin analog produced by reprogramming of polyketide synthesis // Proc Natl Acad Sci U S A. 1993. — V. 90. № 15. — P. 7119−7123.
- Khosla C., Gokhale R.S., Jacobsen J.R., Cane D.E. Tolerance and specificity of polyketide synthases // Annu. Rev. Biochem. 1999. — V. 68. -P. 219−253.
- Rodriguez E., McDaniel R. Combinatorial biosynthesis of antimicrobials and other natural products // Curr. Opin. Microbiol. 2001. — V. 4. — P. 526−534.
- Thomas I., Martin C.J., Wilkinson C.J., Staunton J., Leadlay P.F. Skipping in a hybrid polyketide synthase. Evidence for ACP-to-ACP chain transfer // Chem. Biol. 2002. — V. 9. — P. 781−787.
- Lai R., Kumari R., Kaur H., Khanna R., Dhingra N.3 Tuteja D. Regulation and manipulation of the gene clusters encoding type-I PKSs // Trends Biotechnol. 2000. — V. 18. № 6. — P. 264−274.
- Tang Li, Fu H., McDaniel R. Formation of functional heterologous complexes using subunits from the picromycin, erythromycin and oleandomycin polyketide synthases. // Chemistry & Biology — 2000. — V. 7. № 2. P. 77−84.
- McDaniel R., Welch M.} Hutchinson C.R. Genetic Approaches to Polyketide Antibiotics // Chem. Rev. 2005. — V. 105. — P. 543−558.
- Mendes M.V., Recio E., Fouces R.} Luiten R., Martin J.F., Aparicio J.F. Engineered biosynthesis of novel polyenes: a pimaricin derivative produced by targeted gene disruption in Streptomyces natalensis // Chem. Biol. -2001. V. 8. № 7. — P. 635−644.
- Bohacek R.S., McMartin C., Guida W.C. The Art and Practice of Structure-Based Drug Design: A Molecular Modeling Perspective // Medicinal Research Reviews. 1996. -V. 16. № 1. — P. 3−50.
- Warr W.A. Combinatorial Chemistry and Molecular Diversity. An Overview // J. Chem. Inf. Comput. Sci. 1997. — V. 37. — P. 134−140.
- Green D. Virtual screening of virtual libraries — an efficient strategy for lead generation // Drug Design Cutting Edge Approaches / Ed. Darren R. Flower. UK, Cambridge: The Royal Society of Chemistry, 2002. — P. 7288.
- Molchanova M.S., Shcherbukhin V.V., Zefirov N.S. Computer generation of molecular structures by SMOG program // Journal of Chemical Information and Computer Science 1996. -V. 36. № 4. — P. 888−899.
- Gugisch R., Kerber A., Laue R., Meringer M., Weidinger J. MOLGEN-COMB, a software package for combinatorial chemistry // MATCH — 2000. -V. 41.-P. 189−203.
- Иванов A.C., Веселовский A.B., Дубанов A.B., Скворцов B.C., Арчаков А. И. Интегральная платформа «От гена до прототипа лекарства» in silico и in vitro // Рос. хим. ж. — 2006. — Т. L. № 2. — С. 18−35.
- Xue L., Bajorath J. Molecular Descriptors in Chemoinformatics, Computational Combinatorial Chemistry, and Virtual Screening // Combinatorial Chemistry & High Throughput Screening 2000. — V. 3. — P. 363−372.
- Lengauer T. et al. Novel technologies for virtual screening // Drug Discovery Today 2004. — V. 9. № 1. — P. 27−34.
- Todeschini R., Consonni V. Handbook of Molecular Descriptors. -Weinheim: Wiley-VCH, 2000. 688 p.
- Venkatarajan M.S., Braun W. New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical-chemical properties // J. Mol. Model. 2001. — V. 7. — P. 445−453.
- Pozzan A. Molecular Descriptors and Methods for Ligand Based Virtual High Throughput Screening in Drug Discovery // Current Pharmaceutical Design-2006.-V. 12.-P. 2099−2110.
- Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings // Adv. Drug. Deliv. Rev. 1997. — V. 23.-P. 3−25.
- McGregor M.J., Muskal S.M. Pharmacophore fingerprinting. 1. Application to QSAR and focused library design // J. Chem. Inf. Comput. Sci. 1999. -V. 39.-P. 569−574.
- Mason J.S., Cheney D.L. Library design and virtual screening using multiple point pharmacophore fingerprints // Pac. Symp. Biocomput. — 2000.-V. 5.-P. 576−587.
- Bajorath J. Molecular similarity methods and QSAR models as tools for virtual screening // Drug Discovery Handbook / Ed. Gad S. C. John Wiley & Sons, Inc., 2005.-P. 87−123.
- Pearlman R.S., Smith K.M. Metric validation and the receptor-relevant subspace concept // J. Chem. Inf. Comput. Sci. 1999. — V. 39. — P. 28−35.
- Cruciani G., Crivori P., Carrupt P.A., Testa B. Molecular fields in quantitative structure-permeation relationships: the VolSurf approach // Theochem.-2000. — V. 53.-P. 17−30.
- ROCS 2.3.1 // OpenEye Scientific Software, Inc. August 14, 2007. http://www.eyesopen.com/docs/pdf/rocs.pdf.
- Leach A.R., Gillet V.J. An Introduction to chemoinformatics / Revised ed. by Leach A.R., Gillet VJ. 2nd printing. — Springer, 2007. — 255 p.
- Willett P. Similarity-based virtual screening using 2D fingerprints // Drug Discovery Today 2006. — V. 11. № 23−24.-P. 1043−1056.
- Concepts and Applications of Molecular Similarity / Eds. Johnson M.A., Maggiora G.M. Wiley-Interscience, 1990. — 393 p.
- Grant J.A., Gallardo M.A., Pickup B.T. A Simple Application of a Gaussian Description of Molecular Shape // J. Comput. Chem. 1996. — V. 17.-P. 1653−1666.
- Willet P. Similarity and clustering in Chemical Information Systems. -Letchworth: Research Studies Press, 1987. 266 p.
- Ward J.H. Hierarchical grouping to optimize an objective function // J. Am. Stat. Assoc. 1963. — V. 58. — P. 263−244.
- Jarvis R.A., Patrick E.A. Clustering using a similarity measure based on shared near neighbors // IEEE Trans. Comput. — 1973. — V. C-22. — P. 1025−1034.
- Rose R.R. Machine learning techniques in chemistry // Handbook of chemoinformatics / ed. J. Gasteiger. Wiley-vch, 2003. — P. 1082.
- Chemoinformatics in Drug Discovery / Edited by T.I. Oprea. WILEY-VCH Verlag GmbH & Co, 2005. 493 p.
- Deshpande M., Kuramochi M., Wale N., Karypis G. Frequent Substructure-Based Approaches for Classifying Chemical Compounds // IEEE Transactions on Knowledge and Data Engineering. 2005. — V. 17. № 8. — P. 1036−1050.
- Weber L. Current Status of Virtual Combinatorial Library Design // QSAR Comb. Sci. 2005. — V. 24. — P. 809−823.
- Dudek A.Z., Arodz T., Galvez J. Computational Methods in Developing Quantitative Structure-Activity Relationships (QSAR): A Review //
- Combinatorial Chemistry & High Throughput Screening. — 2006. — V. 9. — P. 213−228.
- Филимонов Д.А., Поройков B.B. Прогноз спектра биологической активности органических соединений // Рос. хим. ж. — 2006. — Т. L. № 2.-С. 66−75.
- WO 01/92 991 A2. Design of polyketide synthase genes / Inventors: Khosla C.- Reid R.- Santi D.- Siani M. Applicant: Kosan Biosciences, Inc. International Filing Date: 29.05.2001- Publication Date: 06.12.2001. -113 p.
- Hatzimanikatis V., Li C., Ionita J.A., Henry C.S., Jankowslci M.D., Broadbelt L.J. Exploring the diversity of complex metabolic networks // Bioinformatics — 2004. V. 21. № 8. — P. 1603−1609.
- Филимонов Д.А., Поройков B.B., Глориозова T.A., Лагунин А.А. Свидетельство об официальной регистрации программы для ЭВМ
- PASS (Prediction of Activity Spectra for Substances) № 2 006 613 275 от 17 сентября 2006 г. Москва, Федеральная служба по интеллектуальной собственности, патентам и товарным знакам.
- Filimonov D.A., Poroikov V.V., Borodina Yu.V., Gloriozova T.A. Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors // J. Chem. Inf. Сотр. Sci. 1999. — V. 39. № 4. — P. 666−670.
- Abu-Gharbieh Е., Vasina V., Poluzzi Е., De Ponti F. Antibacterial macrolides: a drug class with a complex pharmacological profile // Pharmacological Research. 2004. — V. 50. — P. 211−222.
- Dembitsky V. Astonishing diversity of natural surfactants: 2. Polyether glycosidic ionophores and macrocyclic glycosides // Lipids. — 2005. — V. 40.-P. 219−248.
- Dembitsky V.M. Chemistry and Biodiversity of the Biologically Active Natural Glycosides // Chemistry & Biodiversity. 2004. — V. 1. — P. 673−781.
- Kobayashi J., Tsuda M. Amphidinolides, bioactive macrolides from symbiotic marine dinoflagellates // Nat. Prod. Rep. — 2004. — V. 21. — P. 77−93.
- Faulkner D.J. Marine natural products // Nat. Prod. Rep. 2001. — V. 18. -P. 1−49.
- Degerli K., Kilimcioglu A.A., Kurt O., Tamay A.T., Ozbilgin A. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey // Acta Trop. — 2003. — V. 88. № 1. -P. 45−50.
- Stanat S.J., Carlton C.G., Crumb W.J.Jr., Agrawal K.C., Clarkson C.W. Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel // Mol. Cell. Biochem. — 2003.-V. 254. P. 1−7.
- Chen S.Z., Jiang M., Zhen Y.S. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin // Cancer Chemother. Pharmacol. 2005. -V. 56. № 2. — P. 212−220.
- Rodrigues A.D., Roberts E.M., Mulford D.J., Yao Y., Ouellet D. Oxidative metabolism of clarithromycin in the presence of human liver microsomes.
- Major role for the cytochrome P4503A (CYP3A) subfamily // Drug Metab. Dispos. 1997. — V. 25. № 5. — P. 623−630.
- Kenworthy K.E., Bloomer J.C., Clarke S.E., Houston J.B. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates // Br. J. Clin. Pharmacol. 1999. — V. 48. № 5. p. 716−727.
- Schlunzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., Franceschi F. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria // Nature 2001. — V. 413. -P. 814−821.
- Peeters T.L. Erythromycin and other macrolides as prokinetic agents // Gastroenterology 1993.-V. 105. № 6.-P. 1886−1899.
- Doherty W.L., Winter B. Prokinetic agents in critical care // Crit. Care. -2003. V. 7. № 3. -P. 206−208.
- Schultz M.J., Speelman P., van der Poll T. Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-alpha production in human whole blood // J. Antimicrob. Chemother. 2001. — V. 48. № 2. -P. 275−278.
- Suzuki M., Asano K., Yu M., Hisamitsu T., Suzaki H. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo // Mediators Inflamm. 2002. — V. 11. — P. 235−244.
- Mitsuya Y., Kawai S., Kobayashi H. Influence of macrolides on guanosine diphospho-D-mannose dehydrogenase activity in Pseudomonas biofilm // J. Infect. Chemother. 2000. — V. 6. № 1. — P. 45−50.
- US 2005/14 706 Al. Method of treating tuberculosis / Application Number: 10/889,346. Publication Date: 20/01/2005.
- Yatsunami J., Tsuruta N., Fukuno Y., Kawashima M., Taniguchi S., Hayashi S. Inhibitory effects of roxithromycin on tumor angiogenesis, growth and metastasis of mouse B16 melanoma cells // Clin. Exp. Metastasis- 1999.-V. 17. № 2.-P. 119−124.
- Aoki D., Ueno S., Kubo F., Oyama T., Sakuta T., Matsushita K., Maruyama I., Aikou T. Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production // Anticancer Res. -2005.-V. 25. № 1A.-P. 133−138.
- Ohara T., Morishita T., Suzuki H., Masaoka T., Ishii H., Hibi T. Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice // Anticancer Res. 2004. — V. 24. № 6. — P. 3723−3730.
- Shimane T. et al. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro // Mediators Inflamm. — 2001. — V. 10. № 6.-P. 323−332.